ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Lokness who wrote (203)	12/9/1997 3:22:00 AM
From: Jongmans	of 4474

A two pager,from Lehman Brothers' biotech analysts CA Butler.Ph.D/R.Rouse,published 11/04/97. You can, during a short period find this kind of reports on: lehman.com They indicated a price target of $ 11.-. Personally, I think that, based on Ariad's low burnrate, its strong financial backing by Hoechst Marion Roussel and ARIAD's broad and strong researchbase, in the longer run a substantially higher pricelevel is a realistic possibility. Martin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next